Press Releases

Press Releases

Date	Title	Format
May 16, 2023	Chinook Therapeutics Announces Partnership with Ionis to Develop Antisense Therapy for Rare, Severe Chronic Kidney Disease	PDF Version
May 9, 2023	Chinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updates	PDF Version
May 5, 2023	Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	PDF Version
May 5, 2023	Chinook Therapeutics Announces Upcoming Presentations and Investor Conference Call at the 60th European Renal Association (ERA) Congress	PDF Version
April 27, 2023	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
April 13, 2023	Chinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors	PDF Version
April 11, 2023	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
April 11, 2023	Chinook Therapeutics Announces Voluntary Pause in Dosing of CHK-336 in Ongoing Phase 1 Clinical Trial in Healthy Volunteers	PDF Version
April 7, 2023	Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	PDF Version
March 28, 2023	Chinook Therapeutics to Present at the Guggenheim Healthcare Talks \| Genomic Medicines and Rare Disease Days	PDF Version

Email Alerts

Investors